Product news

Share this article:
Bentley Pharmaceuticals announced its European subsidiaries have received approvals to market their omeprazole capsule products, through their licensees, in various territories in Europe. The approvals are for 10 mg. 20 mg. and 40 mg. dosage levels of omeprazole capsules under a Mutual Recognition Procedure (MRP) that grants simultaneous authorizations throughout the EU. Bentley's subsidiaries expect to supply omeprazole to their licensees in the major markets of Germany and Italy, as well as other EU countries. Omeprazole is marketed in the US under the trade name Prilosec by AstraZeneca and under the trade name Losec in Europe.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.

Study says statins not enough for diabetic hearts

Researchers using an experimental test have discovered that the 50% of surveyed diabetics may also have undetected heart muscle damage.